awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33414307-38466E4A-68ED-4233-A3AE-9136B351B164
Q33414307-38466E4A-68ED-4233-A3AE-9136B351B164
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33414307-38466E4A-68ED-4233-A3AE-9136B351B164
A phase I/II study of the pan Bcl-2 inhibitor obatoclax mesylate plus bortezomib for relapsed or refractory mantle cell lymphoma.
P31
Q33414307-38466E4A-68ED-4233-A3AE-9136B351B164
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33414307-38466E4A-68ED-4233-A3AE-9136B351B164
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
1d622312259fc354bef7b632e1650cd9e544b0ad
P31
scholarly article